Trial: A Study to Evaluate the Tolerability of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine.
Purpose: The purpose of this study is to test an experimental drug combination of two medications currently approved by the Food and Drug Administration (FDA) for migraine headache or other pain. These are called rizatriptan given with acetaminophen.
Condition: Migraine
Drug: Maxalt (rizatriptan), acetaminophen
Device:
Procedure: Trial Phase: Phase III
Official Title: A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.
Locations: CA, IL, MI, MO, NY, OH
For more information: http://clinicaltrials.gov/show/NCT00300924
Related content: Triptans: Overview and Profiles (Includes full profile of Maxalt.)
______________
Source:
ClinicalTrials.gov
